ACB $10.020 (-1.96%)

ACNNF $0.111 (14.88%)

AERO $4.530 (0.78%)

AGEEF $0.100 (-2.25%)

ALEAF $0.435 (-3.72%)

AMMJ $0.111 (2.73%)

APHA $4.450 (-3.89%)

ARNA $62.810 (-1.98%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (-2.04%)

AUSA:CNX $0.165 (0%)

AUSAF $0.126 (0.54%)

AVXL $3.925 (-0.63%)

BAMM:CNX $0.340 (6.25%)

BBM:CNX $0.055 (0%)

BBRRF $0.045 (0%)

BE:CNX $0.005 (0%)

BIO:CNX $0.075 (7.14%)

BLEVF $0.004 (11.11%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.480 (-1.03%)

BLOZF $0.361 (0.06%)

BUDZ $0.255 (-1.85%)

BXNG $0.520 (-1.89%)

CADMF $0.618 (-11.14%)

CALI:CNX $0.110 (10%)

CANN $0.400 (0.63%)

CARA $17.430 (1.22%)

CBII:CNX $0.120 (-4%)

CBIIF $0.094 (-1.3%)

CBWTF $0.179 (-0.56%)

CGC $16.950 (-5.47%)

CGRW $0.090 (9.09%)

CHOO:CNX $0.110 (-4.35%)

CHOOF $0.079 (-4.83%)

CNBX $0.195 (-0.51%)

CNGGF $0.310 (0%)

CODI $17.490 (-0.79%)

CPMD $1.850 (-13.95%)

CRBP $6.960 (1.31%)

CRON $5.550 (-4.31%)

CROP:CNX $0.015 (0%)

CRTPF $1.510 (-6.79%)

CRXPF $0.025 (-16.67%)

CSI:CNX $0.920 (0%)

CURR $1.660 (12.16%)

CVSI $0.666 (-4.69%)

DIGP $0.030 (-20.63%)

DXBRF $0.140 (0%)

EAPH $0.001 (57.14%)

EAT:CNX $0.025 (0%)

EEVVF $0.055 (0%)

EMHTF $0.136 (-1.02%)

EPWCF $0.038 (-8.64%)

EVIO $0.018 (-7.89%)

FFRMF $0.030 (7.14%)

FFT:CNX $0.040 (0%)

FNNZF $0.087 (24.39%)

GGTTF $0.085 (-6.66%)

GLDFF $0.017 (-11.46%)

GLH:CNX $0.025 (25%)

GNBT $0.420 (-4.47%)

GRIN:CNX $0.120 (0%)

GRWG $8.610 (-7.12%)

GSTR:CNX $0.090 (0%)

GTBIF $14.470 (-3.47%)

GTII:CNX $19.250 (-3.94%)

GWPH $109.800 (-3.64%)

HEXO $0.705 (-1.73%)

HHPHF $0.003 (4%)

HLSPY $0.440 (0%)

HMLSF $5.080 (-3.04%)

HMPPF $0.498 (0%)

HRVOF $0.053 (-18.34%)

HSTRF $0.104 (0.97%)

HUGE:CNX $3.880 (-3%)

IAN:CNX $0.305 (0%)

IGC $0.639 (-5.97%)

IGXT $0.191 (-7.78%)

IIPR $113.940 (-2.57%)

IMLFF $5.086 (-2.21%)

INQD $0.005 (-13.64%)

IONC:CNX $0.015 (0%)

IONKF $0.020 (17.65%)

ISOL:CNX $0.045 (-10%)

ISOLF $0.035 (-10.94%)

ITHUF $0.063 (-1.88%)

IVITF $0.013 (-16.67%)

JWCAF $0.025 (706.45%)

KALTF $0.001 (0%)

KBEV:CNX $0.075 (7.14%)

KBEVF $0.050 (4.17%)

KHRNF $0.385 (0.03%)

KSHB $0.682 (-0.41%)

LHS:CNX $0.490 (1.03%)

LHSIF $0.374 (1.56%)

LOVE:CNX $0.095 (-5%)

LXRP $0.354 (-3.23%)

LXX:CNX $0.460 (-6.12%)

MCIG $0.028 (0%)

MEDIF $0.781 (0.85%)

MGWFF $0.055 (-4.35%)

MICWF $0.059 (-0.55%)

MJ:CNX $0.035 (-12.5%)

MJNA $0.015 (3.52%)

MNTR $0.082 (1.23%)

MRRCF $0.004 (-5.26%)

MWM:CNX $0.065 (-13.33%)

MYM:CNX $0.070 (0%)

MYMMF $0.058 (3.78%)

NCNNF $0.137 (4.2%)

NDVAF $0.214 (-0.26%)

NGW:CNX $0.230 (-4.17%)

NRXCF $0.096 (-7.83%)

NSPDF $0.051 (-9.11%)

NTEC $0.369 (-8.71%)

NVTQF $0.451 (0%)

NWKRF $0.424 (0%)

NXGWF $0.173 (-3.89%)

NXTTF $0.215 (-2.14%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.009 (-3.28%)

PHCG $0.480 (0%)

PHVAF $0.038 (-7.54%)

PILL:CNX $0.710 (4.41%)

PKG:CNX $0.080 (-5.88%)

PLPRF $0.460 (-2.11%)

PLUS:CNX $0.610 (0%)

PMCB $0.015 (0%)

PNPL $0.110 (0%)

POTN $0.014 (-3.07%)

PRCNF $0.008 (-17.35%)

PTNYF $0.060 (-5.94%)

QCA:CNX $0.110 (0%)

RDDTF $0.106 (2.12%)

RLLVF $0.028 (0%)

RMHB $0.038 (7.97%)

RQB:CNX $0.005 (0%)

RQHTF $0.215 (4.88%)

RVVQF $0.009 (-18.18%)

SLNG:CNX $0.140 (0%)

SMG $154.640 (-0.69%)

SNN:CNX $0.155 (0%)

SNNVF $0.120 (-1.64%)

SOL:CNX $0.440 (4.76%)

SOLCF $0.322 (3.81%)

SPLIF $0.016 (-17.95%)

SPRWF $0.163 (-1.27%)

SRNA $0.032 (-32.13%)

STEM:CNX $0.470 (11.9%)

STMH $0.355 (-11.25%)

SUN:CNX $0.135 (0%)

TBPMF $0.150 (-4.64%)

TCAN:CNX $1.210 (-2.42%)

TCNAF $0.920 (0.22%)

TER:CNX $4.800 (-4.38%)

TGEN $0.690 (-17.71%)

TGIF:CNX $0.065 (-7.14%)

TGIFF $0.050 (-0.99%)

THC:CNX $0.180 (2.86%)

THCBF $0.141 (5.85%)

TLRY $6.930 (-13.05%)

TOKI:CNX $0.030 (0%)

TRLFF $0.031 (5.85%)

TRSSF $3.620 (-3.49%)

TRTC $0.083 (-2.12%)

TURV $0.129 (-0.46%)

VBIO $0.190 (-2.56%)

VIDA:CNX $0.050 (-9.09%)

VIN:CNX $0.025 (-16.67%)

VPRB $0.008 (-10.26%)

VRNDF $0.496 (2.78%)

VRT:CNX $0.180 (0%)

VRTHF $0.118 (-1.01%)

VVCIF $0.184 (-3.01%)

WAYL:CNX $0.740 (0%)

WDDMF $0.287 (7.45%)

WLDFF $0.104 (0%)

XXII $0.711 (-2.05%)

ZDPY $0.170 (-20.91%)

ZYNE $4.070 (-4.01%)

Back

Grit Capital Is Putting On A Can’t Miss Event In The Desert During MJBiz

Nov 25, 2019 • 7:51 AM EST
8 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Next month, thousands of cannabis investors and entrepreneurs will fly to Las Vegas for the MJ Biz Conference.

MJ Biz is by far the largest cannabis conference in the US and this can be overwhelming for people who are new to the industry. During the event, several companies hold exclusive events for people who want to learn about the industry in a less chaotic manner. Our friends over at Grit Capital are throwing a can’t miss event that is sure to be informative and entertaining as always. The event will be held December 12th from 5-8pm at a secret location to be revealed that day. There will also be a SPECIAL PERFORMANCE by a Billboard chart topping artist. To register for the event CLICK HERE!

One of the reasons we are excited about this event is due to the caliber of the companies and the way they are differentiated from each other. During the last year, we have seen a significant increase in the number of businesses that are focused on the cannabis industry and many of these businesses sound identical to each other. Being differentiated is of the utmost importance in the cannabis sector and we are excited about the companies that will be featured at the Grit Capital event.

At the event, you will have the opportunity to learn about Hemptown USA (Private), ManifestSeven (Private), VEXT Sciences (Public, VEXT.CN), CENTR Brands (Public, CNTS-CSE), Pivot Pharmaceuticals (Public, PVOT-CSE) and Captiva Verde (Private). These four companies represent attractive private and public opportunities and we want to highlight each of the businesses.

Hemptown USA: Capitalizing the CBD and CBG Market

Hemptown USA is focused on the production and processing of high-value cannabinoids. The company is specifically focused on the cannabidiol (CBD) and cannabigerol (CBG) opportunities and has visible catalysts for growth. Hemptown recently completed several harvests and we expect to see the business generate significant cash flow from it.

During the last year, there has been a significant increase in the number of companies that are focused on the CBD opportunity. This has caused the CBD market to see significant price compression and this is a trend that we are following. Hemptown has been able to sell CBG for up to 10 times more than the CBD it produced, and we are favorable on the leverage to this product segment.

By being focused on the production of CBG, Hemptown has been able to help insulate itself from price compression and this is something that we are excited about. Next year, the company plans to complete a go-public transaction and we expect to see strong demand for this opportunity. The GRIT event provides an exciting opportunity to meet and engage with the Hemptown team and we are excited about this.

VEXT Science: A High-Growth US Cannabis Concentrate Business

The vaping health crisis has been a major headwind for the cannabis industry and Vext Science (VAPN.CN) (VAPNF) has been hit especially hard by it. Initially, the company was only focused on the Arizona medical cannabis market and we are impressed by how the story has evolved so far this year. By also focusing on the CBD market, the company has been able to expand into strategic U.S. markets through joint venture partnerships. We are favorable on the growth prospects associated with the expanded market position and expect the business to report ramping revenues on a quarter-over-quarter basis.

Over the next year, we expect VEXT to report incremental revenue growth and we are favorable on the assets and the relationships that are in place. During the first half of the year, the company generated more than $13 million of revenue in Arizona. Once these new markets (Oklahoma and Nevada) come online and start generating revenues, we expect the company to report significant revenue growth and believe that this opportunity is flying under the radar.

Although the company has been nothing short of an execution story so far this year, the shares have been under considerable pressure and this is a trend that we are watching. We believe that the company is led by a management team that has a firm understanding of where the cannabis industry is going and believe that the business is well positioned to take advantage of this. We are excited to meet with the team at the GRIT event and this is an opportunity to be aware of.

ManifestSeven: A Leading California Cannabis Operation

ManifestSeven (M7) is focused on providing real world solutions for the cannabis sector and we are looking forwad to catchin up with the team. In the near future, the company expects to commence trading on the CSE and we are bullish on the growth prospects associated with the company. M7 been highly focused on the California cannabis industry since 2014 and owns a basket of companies that are levered to the entire cannabis value chain.

M7 started out as a venture investment firm under the MJIC banner and evaluated hundreds of cannabis and ancillary companies to date. In 2017, Sturges Karban was appointed as CEO and has transitioned the company into California’s first omnichannel model for legal cannabis, servicing both business-to- business (B2B) and business-to-consumer (B2C).

One of the first words that comes to mind with M7 is control and we believe that this is a very important aspect of the cannabis industry from a safety standpoint. The company controls distribution, delivery and dispensary, on its seamless platform. Compliance is a priority for the business, and we believe that this is one of the most important aspects when it comes to building a platform that can be trusted.

M7 is highly focused on distribution and retail because there is an unmatched ability to curate a product portfolio for entire space. By focusing on retail and distribution, M7 has much more control over what goes to market and what becomes a best seller. We are favorable on the way the company will be able to understand the market through this focus and are excited about the vision of the business.

California the largest cannabis market in the world and you will have an opportunity to learn about M7 at GRIT Capital. Over the next year, we expect the company to be a major beneficiary of the cannabis movements and this is an opportunity to have on your radar.

CENTR Brands: Developing CBD infused sparkling beverage line

CENTR Brands Corp. is a Vancouver– based beverage company that has developed a line of sparkling beverages containing Cannabidiol for initial distribution on the West Coast of the United States, with eventual expansion nationally and internationally. The Company’s initial products are known as CENTR. The Company is led by an executive team with significant entrepreneurial experience in branding and design, finance, and sales and distribution.

Pivot Pharma

Pivot Pharmaceuticals CSE:PVOT: Advanced Consumer CBD and Nutraceutical Products Lead by Advisor Joe Mimran CPG & Fashion Icon 

Pivot Pharmaceuticals Inc. is an emerging nutraceutical consumer products company that uses innovative and patented drug delivery technologies along with unique and cutting-edge branding.  Pivot has a suite of consumer CBD and Nutraceutical products. Pivot’s Micelle CBD product is 4-20x more bio-available than current products in the market along with being accurate to dose and water soluble. With product available in Germany, Pivot will also be launching in Canada & the U.S. in Q1/2020 under a new brand developed legendary branding expert Joe Mimran who successfully launched Club Monaco & Alfred Sung, and Joe Fresh.

Captiva Verde

Captiva Verde (CSE:PWR) (OTC:CPIVF), through its Mexican subsidiary, holds a pharmaceutical license in Mexico that allows us to manufacture, distribute and sell throughout Mexico, over 300 different types of narcotics and psychoactive medicines, including cannabis and psilocybin. The company has an arrangement with the health care workers union in Mexico to distribute products. We provide shareholders an enhanced cannabis business model based on hard infrastructure assets, substantial real estate ownership, farming, and IP to further reduce financial risk while providing high demand niche organic products to our established international customers for sustainable positive financial cash flows for future growth and shareholder value.

 

 

 

 

 

 

 

 

Pursuant to an agreement between StoneBridge Partners LLC and HTO Holdings we have been hired for a period of 180 days beginning June 17, 2019 and ending December 17, 2019 to publicly disseminate information about (Private) including on the Website and other media including Facebook and Twitter. We are being paid $7,500 per month (Private) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (Private), which we purchased in the open market. We plan to sell the “ZERO” shares of (Private) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (Private) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Pursuant to an agreement between StoneBridge Partners LLC and Manifest7. (MSVN) we have been hired for a period of 180 days beginning August 1, 2019 and ending February 1, 2020 to publicly disseminate information about (MSVN) including on the Website and other media including Facebook and Twitter. We are being paid $10,000 per month for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (MSVN), which we purchased in the open market. We may buy or sell additional shares of (MSVN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.